Loading...
PepGen Inc.
PEPG•NASDAQ
HealthcareBiotechnology
$1.50
$-0.03(-1.63%)
PepGen Inc. (PEPG) Financial Performance & Statements
Review PepGen Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
100.00%
↑ 100.00%
Net Income Growth
-14.44%
↓ 14.44%
Operating Cash Flow Growth
-19.38%
↓ 19.38%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-81.26%
↓ 81.26%
ROIC
-102.15%
↓ 102.15%
PepGen Inc. (PEPG) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for PepGen Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Net Income | -$22.24M | -$21.38M | -$28.34M | -$18.02M |
| Depreciation & Amortization | $1.32M | $1.32M | $370000.00 | $376000.00 |
| Deferred Income Tax | $0.00 | $0.00 | $0.00 | $0.00 |
| Stock Based Compensation | $3.35M | $3.23M | $2.86M | $2.02M |
| Change In Working Capital | -$927000.00 | -$1.64M | $7.92M | -$6.28M |
| Accounts Receivables | $0.00 | $0.00 | $0.00 | $0.00 |
| Inventory | $0.00 | $0.00 | $0.00 | $0.00 |
| Accounts Payables | -$4.19M | -$1.67M | $6.50M | $88000.00 |
| Other Working Capital | $3.27M | $36000.00 | $1.42M | -$6.37M |
| Other Non-Cash Items | -$970000.00 | -$5.53M | -$2.07M | $2.06M |
| Net Cash From Operating Activities | -$19.48M | -$24.01M | -$16.35M | -$22.53M |
| Investments In Property Plant & Equipment | -$228000.00 | -$185000.00 | -$31000.00 | -$53000.00 |
| Acquisitions Net | $0.00 | $0.00 | $0.00 | $0.00 |
| Purchases Of Investments | -$21.27M | -$29.95M | -$64.71M | -$29.24M |
| Sales/Maturities Of Investments | $48.00M | $30.00M | $12.00M | $18.00M |
| Other Investing Activities | $0.00 | $1.00 | -$52713.00 | -$11239.00 |
| Net Cash Used For Investing Activities | $26.50M | -$133000.00 | -$52.74M | -$11.29M |
| Debt Repayment | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Issued | $0.00 | -$11.42M | $1.33M | $86.78M |
| Common Stock Repurchased | $0.00 | $0.00 | $0.00 | $0.00 |
| Dividends Paid | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Financing Activities | $128000.00 | $327000.00 | $1.33M | $189000.00 |
| Net Cash From Financing Activities | $128000.00 | $327000.00 | $1.33M | $86.97M |
| Effect Of Forex Changes On Cash | -$22000.00 | $22000.00 | $1000.00 | -$63000.00 |
| Net Change In Cash | $7.13M | -$23.80M | -$67.77M | $53.08M |
| Cash At End Of Period | $50.97M | $43.84M | $66.08M | $133.85M |
| Cash At Beginning Of Period | $43.84M | $67.63M | $133.85M | $80.77M |
| Operating Cash Flow | -$19.48M | -$24.01M | -$16.35M | -$22.53M |
| Capital Expenditure | -$228000.00 | -$185000.00 | -$31000.00 | -$53000.00 |
| Free Cash Flow | -$19.70M | -$24.20M | -$16.38M | -$22.59M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan